Moreover, the MBD2 protein level was significantly elevated in the well-known molecular subtypes of human breast tumors [luminal, Her2-positive, and triple-negative breast cancer (TNBC)] (Fig. 1b). This evidence concerns the gene MBD2 and triple-negative breast carcinoma.